Clinical Trials · NCT00572689
Pilot Study of Exenatide Pharmacokinetics and Pharmacodynamics in Gestational Diabetes
- Phase
- Phase 4
- Recruitment status
- Withdrawn
- Sponsor
- Georgetown University
- Enrollment
- 0
- Start date
- Aug 2013
- Locations
- 2 sites, United States
- Primary endpoint
- glycemic control through insulin, glucose, c-peptide and glucagon assays